Covered recipient · General Payments record
CAROLYN E ZYLONEY
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$3,260.11
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $820.95 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $126.72 | 2 |
| Alnylam Pharmaceuticals Inc. | $125.01 | 1 |
| UCB, Inc. | $120.51 | 4 |
| Neurelis, Inc. | $118.19 | 1 |
| Genentech USA, Inc. | $109.80 | 1 |
| ABBVIE INC. | $78.12 | 1 |
| PFIZER INC. | $46.64 | 2 |
| Biogen, Inc. | $26.72 | 1 |
| JAZZ PHARMACEUTICALS INC. | $26.27 | 1 |
| Lilly USA, LLC | $24.13 | 1 |
| Otsuka America Pharmaceutical, Inc. | $18.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $78.12 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402835 | CMS |
| Alnylam Pharmaceuticals Inc. | $125.01 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125853467 | CMS |
| Amgen Inc. | $111.17 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111747867 | CMS |
| Amgen Inc. | $15.55 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111747865 | CMS |
| Biogen, Inc. | $26.72 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104805999 | CMS |
| Genentech USA, Inc. | $109.80 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132984933 | CMS |
| JAZZ PHARMACEUTICALS INC. | $26.27 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150234662 | CMS |
| Lilly USA, LLC | $24.13 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136087862 | CMS |
| Neurelis, Inc. | $118.19 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145659483 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.84 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119009999 | CMS |
| PFIZER INC. | $24.64 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131718337 | CMS |
| PFIZER INC. | $22.00 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131840008 | CMS |
| UCB, Inc. | $39.72 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143220044 | CMS |
| UCB, Inc. | $25.29 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143220049 | CMS |
| UCB, Inc. | $22.83 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143220053 | CMS |
| UCB, Inc. | $32.67 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143220058 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.